About 14 million living Americans have had cancer and 1.6 million cases occur each year. Some are not life-threatening but many are and cancer is perhaps the illness which creates the greatest anxiety about care among its sufferers. An Institute of Medicine report examines the state of cancer care in the US, with recommendations for improvement. (IOM Report) Cancer care cost about $125 billion in 2010 and the costs are rising rapidly, largely due to better survival times and more expensive specialty drugs. Much of the cost of this care is placed on patients through deductibles and copays and even drug coinsurance. This raises questions about access to needed care. The IOM expressed concern about the extent of patient involvement in care decisions, through shared decision-making and other methods, particularly for patients who are likely terminal. Palliative care is not always used, which may create unnecessary discomfort from the effects of drugs, radiation and other treatment. And although many guidelines for various cancers exist, care is still not often provided in accordance with these guidelines, which may lower outcomes and increase costs. Another significant problem is the adequacy of the work force, given trends in cancer frequency. To address these issues, the IOM recommended six key components to a cancer care system: engaged patients; a trained and coordinated cancer care workforce; consistent use of evidence-based care; better IT specifically for cancer treatment; quality improvement systems and ensuring access, including affordability. The report provides a good roadmap, but in a fragmented system, we will see what the chances of implementation are.
Cancer Care Report
By Kevin RocheOctober 4, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…